Relay Therapeutics Inc (RLAY)
5.84
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
5.85
+0.01
(+0.17%)
Pre-Market: 20:00
Relay Therapeutics Price: 5.84 for Nov. 4, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 04, 2024 | 5.78 | 6.035 | 5.65 | 5.84 | 1.110M |
| Nov 01, 2024 | 5.69 | 6.00 | 5.63 | 5.84 | 1.259M |
| Oct 31, 2024 | 5.71 | 5.755 | 5.60 | 5.635 | 1.022M |
| Oct 30, 2024 | 5.85 | 6.09 | 5.695 | 5.71 | 1.029M |
| Oct 29, 2024 | 6.00 | 6.15 | 5.77 | 5.90 | 1.108M |
| Oct 28, 2024 | 6.06 | 6.17 | 5.93 | 6.03 | 2.589M |
| Oct 25, 2024 | 6.22 | 6.380 | 6.00 | 6.02 | 862711.0 |
| Oct 24, 2024 | 6.35 | 6.41 | 6.02 | 6.19 | 1.081M |
| Oct 23, 2024 | 6.59 | 6.645 | 6.20 | 6.30 | 1.172M |
| Oct 22, 2024 | 6.35 | 6.69 | 6.34 | 6.66 | 980955.0 |
| Oct 21, 2024 | 6.68 | 6.77 | 6.42 | 6.43 | 904305.0 |
| Oct 18, 2024 | 6.64 | 6.84 | 6.56 | 6.73 | 909348.0 |
| Oct 17, 2024 | 6.71 | 6.85 | 6.46 | 6.64 | 1.090M |
| Oct 16, 2024 | 6.81 | 6.94 | 6.68 | 6.80 | 1.157M |
| Oct 15, 2024 | 6.71 | 6.90 | 6.55 | 6.74 | 1.565M |
| Oct 14, 2024 | 6.73 | 7.07 | 6.728 | 6.75 | 1.499M |
| Oct 11, 2024 | 6.52 | 6.98 | 6.46 | 6.80 | 2.710M |
| Oct 10, 2024 | 6.28 | 6.70 | 6.180 | 6.58 | 2.184M |
| Oct 09, 2024 | 6.20 | 6.50 | 5.93 | 6.41 | 3.578M |
| Oct 08, 2024 | 6.32 | 6.45 | 6.23 | 6.25 | 906968.0 |
| Oct 07, 2024 | 6.55 | 6.56 | 6.26 | 6.34 | 1.120M |
| Oct 04, 2024 | 6.56 | 6.63 | 6.381 | 6.53 | 1.262M |
| Oct 03, 2024 | 6.39 | 6.55 | 6.315 | 6.49 | 1.386M |
| Oct 02, 2024 | 6.52 | 6.59 | 6.27 | 6.49 | 1.977M |
| Oct 01, 2024 | 7.01 | 7.035 | 6.53 | 6.55 | 1.693M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
5.635
Minimum
Oct 31 2024
61.53
Maximum
Jan 22 2021
22.19
Average
20.20
Median
Price Benchmarks
| Pfizer Inc | 27.76 |
| Summit Therapeutics Inc | 19.96 |
| Biomarin Pharmaceutical Inc | 66.00 |
| Lexicon Pharmaceuticals Inc | 1.205 |
| Arbutus Biopharma Corp | 3.86 |
Price Related Metrics
| PS Ratio | 21.11 |
| Price to Book Value | 1.147 |
| Earnings Yield | -43.15% |
| Market Cap | 781.92M |